A recent case series and literature review highlights the occurrence of organizing pneumonia associated with ocrelizumab treatment in multiple sclerosis patients. This finding underscores the need for awareness of potential pulmonary complications in MS therapies.
ocrelizumab related organizing pneumonia in multiple sclerosis insights from a case series and literature review
Original title: “Ocrelizumab-related organizing pneumonia in multiple sclerosis: insights from a case series and literature review.”